FDA moves to fast-track 3 psychedelic drugs for review
Digest more
The FDA has introduced a new fast-track review system for three psychedelic drug programs targeting PTSD and depression, potentially cutting approval review times to one or two months once ...
Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results